Analysis of baseline laboratory characteristics of HIV-positive patients in Bulgaria treated with bictegravir /emtricitabine/ tenofovir anafelamide (early analysis)
<p>Introduction: Bictegravir/Emtricitabine/Tenofovir Anafelamide (B/F/TAF) is a recommended single tablet regimen with good tolerability and safety as well as durability of the virologic response. From its introduction in the country of Bulgaria in April 2021 till November 2021 it was given to...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Book |
| Published: |
Annals of Antivirals and Antiretrovirals - Peertechz Publications,
2024-01-04.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|